What the science says about melatonin now
Melatonin is a hormone produced by the pineal gland that signals nighttime to the body; synthetic supplements are widely used for sleep timing issues such as jet lag, shift work, and delayed sleep-wake rhythm. Current studies emphasize modest benefits for sleep onset and alignment rather than increases in total sleep time, with the strongest evidence supporting use when circadian rhythms are shifted. This overview summarizes what is reliably known about melatonin’s effects, appropriate dosing, safety, populations of interest, and where research remains limited.
How melatonin works and what it does
Circadian timing and receptor actions
Melatonin binds primarily to MT1 and MT2 receptors in the suprachiasmatic nucleus and other tissues, reducing alertness and lowering core body temperature, which facilitates sleep at night. Because it does not strongly redistribute sleep across the night, it is most helpful when the goal is to fall asleep earlier or to realign the internal clock rather than to add substantial total sleep. Light exposure at night strongly suppresses endogenous melatonin release, which is one reason night-screen use and irregular schedules disrupt sleep.
Key pharmacologic features
- Half-life: about 20–50 minutes in healthy adults, though slightly longer in older adults and with certain formulations
- Time to peak: roughly 30–60 minutes after oral intake
- Common doses in studies: 0.3–5 mg, with lower physiological doses often as effective as higher ones for circadian shifts
Recent research themes and findings
Over the past several years, systematic reviews and randomized trials have converged on a modest but consistent effect of melatonin for advancing sleep timing, particularly in neurodevelopmental conditions and in older adults whose endogenous production declines. Research has also addressed formulation differences, timing of intake, and how endogenous production varies by age and light exposure. While study quality varies, the overall conclusion is that melatonin is most reliable when used strategically to shift circadian rhythms rather than as a general sleep tonic.
Dosing, timing, and practical guidance
Dose and schedule recommendations
Because melatonin’s effects occur at very low physiologic concentrations, standard clinical guidance is to start low (0.3–1 mg) and increase gradually only if needed. For jet lag and sleep-wake shifts, taking melatonin close to the target sleep time—often early evening for eastward travel or upon waking for westward travel—tends to be more effective than taking large doses. Controlled-release and slow-release formulations may better mimic natural melatonin release and may reduce morning drowsiness for some people.
Practical comparison of common product types
| Type | What it aims to do | When people often use it |
|---|---|---|
| Immediate-release | Raise melatonin quickly then taper | Sleep onset difficulties and short-term shifts |
| Controlled-release | Prolonged, more natural rise and decline | Maintenance through the night, reduce next-morning grogginess |
| Combination formulations | Pair melatonin with other nutrients | Self-managed use, convenience |
Safety, side effects, and cautions
Melatonin is generally well tolerated at low short-term doses; the most common complaints are morning drowsiness, headache, and dizziness. Intermountain Healthcare notes that interactions can occur with anticoagulants, immunosuppressants, some anticonvulsants, and other central nervous system depressants. Because regulatory pathways for supplements differ from medicines, product potency and purity can vary; choosing third-party-tested brands is advisable, especially in populations such as older adults and people with neurologic or metabolic conditions.
Special populations and context
Children, adolescents, and neurodivergent individuals
Evidence suggests melatonin can be effective for short-term sleep timing issues in children with neurodevelopmental disorders, but because of unknowns about long-term use, clinicians typically use the lowest effective dose and prioritize behavioral sleep routines. Parents and guardians should coordinate closely with a pediatric clinician to balance benefits and risks and to monitor for changes in sleep, behavior, or daytime functioning.
Older adults
Aging is associated with reduced endogenous melatonin production and more fragmented sleep. Low doses often help consolidate sleep and reduce early morning awakenings, but higher amounts do not necessarily yield better results and may increase next-day sedation. For older adults, strategies such as morning light exposure, consistent sleep-wake schedules, and evening sleep hygiene remain important alongside any melatonin use.
Where the evidence is thin
Key gaps remain, including long-term safety in children and adolescents, optimal dosing across diverse populations, and how melatonin performs for chronic insomnia not tied to circadian misalignment. Reviews to date indicate low to moderate certainty for many outcomes, and they highlight the need for larger, well-controlled studies, particularly in people with medical comorbidities and psychiatric conditions. Conflicts of interest and industry funding in some studies also underscore the need for independent research.
Practical takeaways
- Use low doses (0.3–1 mg) and advance gradually if you are shifting your sleep schedule.
- Take close to your target sleep time for circadian shifts; timing matters more than high doses.
- Prefer third-party-tested products and discuss use with a clinician if you take other medications or have chronic health conditions.
- Combine melatonin with consistent sleep-wake times, morning light, and reduced evening light for best results.
- Reserve higher or long-term use for supervised care, especially in children and older adults.